These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 17718696)
1. Clinical and experimental features of MuSK antibody positive MG in Japan. Ohta K; Shigemoto K; Fujinami A; Maruyama N; Konishi T; Ohta M Eur J Neurol; 2007 Sep; 14(9):1029-34. PubMed ID: 17718696 [TBL] [Abstract][Full Text] [Related]
2. MuSK antibody-positive, seronegative myasthenia gravis in Korea. Lee JY; Sung JJ; Cho JY; Oh DH; Kim HJ; Park JH; Lee KW; Choi YC; Vincent A J Clin Neurosci; 2006 Apr; 13(3):353-5. PubMed ID: 16546389 [TBL] [Abstract][Full Text] [Related]
3. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509 [TBL] [Abstract][Full Text] [Related]
6. Long-Lasting Rituximab-Induced Reduction of Specific-But Not Total-IgG4 in MuSK-Positive Myasthenia Gravis. Marino M; Basile U; Spagni G; Napodano C; Iorio R; Gulli F; Todi L; Provenzano C; Bartoccioni E; Evoli A Front Immunol; 2020; 11():613. PubMed ID: 32431692 [TBL] [Abstract][Full Text] [Related]
7. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis. Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539 [TBL] [Abstract][Full Text] [Related]
8. [A case of myasthenia gravis with anti-MuSK antibodies showing a dramatic improvement with plasma exchange]. Suzuki H; Motomura M; Yoshimura T; Shiraishi H; Mitsui Y; Hasegawa T; Atsumi M; Kitaguchi M; Kusunoki S Rinsho Shinkeigaku; 2005 Jul; 45(7):510-3. PubMed ID: 16119834 [TBL] [Abstract][Full Text] [Related]
9. Longitudinal epitope mapping in MuSK myasthenia gravis: implications for disease severity. Huijbers MG; Vink AF; Niks EH; Westhuis RH; van Zwet EW; de Meel RH; Rojas-García R; Díaz-Manera J; Kuks JB; Klooster R; Straasheijm K; Evoli A; Illa I; van der Maarel SM; Verschuuren JJ J Neuroimmunol; 2016 Feb; 291():82-8. PubMed ID: 26857500 [TBL] [Abstract][Full Text] [Related]
10. [Seronegative myasthenia and myasthenia gravis with anti-MuSK antibody: a retrospective study of 20 cases]. Aubert S; Salort-Campana E; Franques J; Uzenot D; Pouget J Rev Neurol (Paris); 2009 Nov; 165(11):901-10. PubMed ID: 19327804 [TBL] [Abstract][Full Text] [Related]
11. MuSK-positive myasthenia gravis is rare in the Polish population. Kostera-Pruszczyk A; Kamińska A; Dutkiewicz M; Emeryk-Szajewska B; Strugalska-Cynowska MH; Vincent A; Kwieciński H Eur J Neurol; 2008 Jul; 15(7):720-4. PubMed ID: 18494794 [TBL] [Abstract][Full Text] [Related]
12. Prepubertal anti-Musk positive myasthenia gravis with long remission. Gungor-Tuncer O; Orhan EK; Yilmaz V; Parman Y; Oflazer P; Saruhan-Direskeneli G; Deymeer F Neuromuscul Disord; 2014 Jan; 24(1):36-9. PubMed ID: 24074501 [TBL] [Abstract][Full Text] [Related]